-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Eiger BioPharmaceuticals, Inc. annual/quarterly Depreciation, Depletion and Amortization history and growth rate from Q1 2020 to Q1 2023.
- Eiger BioPharmaceuticals, Inc. Depreciation, Depletion and Amortization for the quarter ending March 31, 2023 was $74K, a 1.37% increase year-over-year.
- Eiger BioPharmaceuticals, Inc. annual Depreciation, Depletion and Amortization for 2023 was $275K, a 5.82% decline from 2022.
- Eiger BioPharmaceuticals, Inc. annual Depreciation, Depletion and Amortization for 2022 was $292K, a 5.8% increase from 2021.
- Eiger BioPharmaceuticals, Inc. annual Depreciation, Depletion and Amortization for 2021 was $276K, a 65.3% increase from 2020.
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)